Back

Evaluating ANO6 as a Parkinson's disease candidate gene: a human genetic investigation of common and rare variant associations

Parlar, S. C.; Leonard, H.; Senkevich, K.; Liu, L.; Teferra, M.; The Global Parkinson's Genetics Program (GP2), ; Gan-Or, Z.

2026-01-23 genetic and genomic medicine
10.64898/2026.01.21.26344547 medRxiv
Show abstract

ANO6 (TMEM16F), a Ca2{square}-activated lipid scramblase and ion channel, has been implicated in -synuclein secretion and propagation, a hallmark of Parkinsons disease (PD). To evaluate whether genetic variation in ANO6 contributes to PD risk, we analyzed common and rare variants across large-scale datasets. Relying on genome-wide association study (GWAS) summary statistics from 63,555 PD cases, 17,700 proxy cases, and 1.7 million controls, we identified seven noncoding common variants within ANO6 that reached genome-wide significance, but these signals were driven by linkage disequilibrium (LD) with the nearby LRRK2 p.G2019S variant. We further tested rare variant burden in 4,879 PD cases and 65,279 controls. Rare variant burden analysis showed significant enrichment only when all rare variants were aggregated (meta-analysis PFDR = 0.02), with no signal detected in functional categories. Overall, human genetic data does not support an important role for ANO6 in PD.

Matching journals

The top 4 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.